Clinical Trial Update: Intravenous Magnesium Infusion in Patients Undergoing Cardioversion of Atrial Fibrillation Trial [NA]

View source ↗

Summary

A completed clinical trial evaluating intravenous magnesium infusion during cardioversion in patients with atrial fibrillation; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Magnesium infusion (magnesium)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2020-10-22